Event Horizon Telescope: Imaging a Black Hole Through Global Collaboration (Video Available)

Speaker: Shep Doeleman, PhD, at Center for Astrophysics

Date: November 9, 2020 at 4:00PM - 5:30PM

What can medicine learn about collaboration and data sharing from one of the most successful team science projects of all time--creating a telescope the diameter of the earth to snap an image of a black hole? Black holes are cosmic objects so massive and dense that their gravity forms an event horizon: a region of spacetime from which nothing, not even light, can escape. Einstein's theories predict that a distant observer should see a ring of light encircling the black hole, which forms when radiation emitted by infalling hot gas is lensed by the extreme gravity. The Event Horizon Telescope (EHT) is a global array of radio dishes that forms an Earth-sized virtual telescope, which can resolve the nearest supermassive black holes where this ring feature may be measured. On April 10th, 2019, the EHT project reported success: we have imaged a black hole and have seen the predicted strong gravitational lensing that confirms the theory of General Relativity at the boundary of a black hole.  This talk will describe the project, and the global collaborative approach that produced these first results, as well as future directions that will enable real-time black hole movies.

Shep Doeleman, PhD is an Astrophysicist at the Center for Astrophysics and the Founding Director of the Event Horizon Telescope (EHT) project, a synchronized global array of radio observatories designed to examine the nature of black holes. Dr. Doeleman led the international team of researchers that produced the first directly observed image of a black hole. Dr. Doeleman was awarded the 2020 Breakthrough Prize in Fundamental Physics as the Founding Director of the EHT Collaboration for the first image of a supermassive black hole. Dr. Doeleman was named one of the 100 Most Influential People of 2019 by Time magazine.

 


Publications

Hopper RK, Abman SH, Elia EG, Avitabile CM, Yung D, Mullen MP, Austin ED, Bates A, Handler SS, Feinstein JA, Ivy DD, Kinsella JP, Mandl KD, Raj JU, Sleeper LA, . Pulmonary Hypertension in Children with Down Syndrome: Results from the Pediatric Pulmonary Hypertension Network Registry. The Journal of pediatrics 2022.

Wang X, Zhang HG, Xiong X, Hong C, Weber GM, Brat GA, Bonzel CL, Luo Y, Duan R, Palmer NP, Hutch MR, Gutiérrez-Sacristán A, Bellazzi R, Chiovato L, Cho K, Dagliati A, Estiri H, García-Barrio N, Griffier R, Hanauer DA, Ho YL, Holmes JH, Keller MS, Klann MEng JG, L'Yi S, Lozano-Zahonero S, Maidlow SE, Makoudjou A, Malovini A, Moal B, Moore JH, Morris M, Mowery DL, Murphy SN, Neuraz A, Yuan Ngiam K, Omenn GS, Patel LP, Pedrera-Jiménez M, Prunotto A, Jebathilagam Samayamuthu M, Sanz Vidorreta FJ, Schriver ER, Schubert P, Serrano-Balazote P, South AM, Tan ALM, Tan BWL, Tibollo V, Tippmann P, Visweswaran S, Xia Z, Yuan W, Zöller D, Kohane IS, Avillach P, Guo Z, Cai T, . SurvMaximin: Robust federated approach to transporting survival risk prediction models. Journal of biomedical informatics 2022.

Torous J, Stern AD, Bourgeois FT. Regulatory considerations to keep pace with innovation in digital health products. NPJ digital medicine 2022.

Levy S, Wisk LE, Minegishi M, Ertman B, Lunstead J, Brogna M, Weitzman ER. Association of Screening and Brief Intervention With Substance Use in Massachusetts Middle and High Schools. JAMA network open 2022.

Nielsen M, Presti M, Sztupinszki Z, Jensen AWP, Draghi A, Chamberlain CA, Schina A, Yde CW, Wojcik J, Szallasi Z, Crowther MD, Svane IM, Donia M. Co-existing alterations of MHC class I antigen presentation and IFNγ signaling mediate acquired resistance of melanoma to post-PD-1 immunotherapy. Cancer immunology research 2022.